Structural determinants for integrase pleiotropism in viral maturation

病毒成熟过程中整合酶多效性的结构决定因素

基本信息

  • 批准号:
    10363022
  • 负责人:
  • 金额:
    $ 34.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-01 至 2022-08-31
  • 项目状态:
    已结题

项目摘要

Abstract The studies in Project 1 will center on elucidating structural determinants for a second, non-catalytic function of HIV-1 integrase (IN) during virion maturation. While an essential role of IN for integration of viral cDNA into human chromosome during early steps of HIV-1 infection has been long established and successfully exploited as a therapeutic target, the recent studies with allosteric IN inhibitors (ALLINIs) by HIVE investigators coupled with earlier site-directed mutagenesis experiments have suggested that IN plays an active role in viral particle maturation. During the past funding period our studies with ALLINIs, a new class of very promising antiviral compounds, which are currently in clinical trials, have uncovered that these inhibitors induce hyper or aberrant multimerization of HIV-1 IN and yield eccentric, non-infectious virions where the ribonucleoprotein complexes (RNPs) are mislocalized outside of the translucent capsid cores. Subsequent collaborative efforts by HIVE and CRNA investigators have revealed that IN binds the viral RNA genome to ensure correct localization of RNPs within the protective capsid core, whereas ALLINI treatments impair IN-RNA interactions and result in the eccentric core phenotype. These seminal findings will now be extended to elucidate key structural interactions that underlie these biological events. In particular, our experiments will take advantage of cutting-edge technologies available within the HIVE center as well as utilize complementary expertise of CRNA and PCHPI scientists to accomplish the following aims. Aim 1 will determine the cryo-EM structure of IN bound to a cognate RNA element; aim 2 will dissect complementary interactions of IN and nucleocapsid with viral RNA using single molecule fluorescence and SHAPE; aim 3 will examine the significance of IN-RNA interactions in non-primate lentiviruses and other retroviruses using CLIP-seq and biochemical approaches; aim 4 will investigate the structural basis for ALLINI induced hyper-multimerization of full length wild type IN using solid state NMR and free energy calculations; and aim 5 will generate mesoscale models of correctly matured and ALLINI treated eccentric virus particles. These highly innovative experiments will push the boundaries of rapidly developing technologies such as single particle cryo-EM, solid-state NMR and computational modeling as well as critically advance our understanding of molecular events that shape the formation of infectious virions.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mamuka Kvaratskhelia其他文献

Mamuka Kvaratskhelia的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mamuka Kvaratskhelia', 18)}}的其他基金

Imaging early steps of HIV-1 infection and virus-host factor interactions
HIV-1 感染的早期成像和病毒-宿主因子相互作用
  • 批准号:
    10548587
  • 财政年份:
    2022
  • 资助金额:
    $ 34.32万
  • 项目类别:
Imaging early steps of HIV-1 infection and virus-host factor interactions
HIV-1 感染的早期成像和病毒-宿主因子相互作用
  • 批准号:
    10646359
  • 财政年份:
    2022
  • 资助金额:
    $ 34.32万
  • 项目类别:
Multimeric HIV-1 Integrase Inhibitors
多聚体 HIV-1 整合酶抑制剂
  • 批准号:
    10570935
  • 财政年份:
    2019
  • 资助金额:
    $ 34.32万
  • 项目类别:
Multimeric HIV-1 Integrase Inhibitors
多聚体 HIV-1 整合酶抑制剂
  • 批准号:
    10348747
  • 财政年份:
    2019
  • 资助金额:
    $ 34.32万
  • 项目类别:
Multimeric HIV-1 Integrase Inhibitors
多聚体 HIV-1 整合酶抑制剂
  • 批准号:
    9893809
  • 财政年份:
    2019
  • 资助金额:
    $ 34.32万
  • 项目类别:
Multimeric HIV-1 Integrase Inhibitors
多聚体 HIV-1 整合酶抑制剂
  • 批准号:
    9037577
  • 财政年份:
    2014
  • 资助金额:
    $ 34.32万
  • 项目类别:
Core B: Proteomics and Protein Analysis Core
核心 B:蛋白质组学和蛋白质分析核心
  • 批准号:
    8742037
  • 财政年份:
    2014
  • 资助金额:
    $ 34.32万
  • 项目类别:
Multimeric HIV-1 Integrase Inhibitors
多聚体 HIV-1 整合酶抑制剂
  • 批准号:
    8748522
  • 财政年份:
    2014
  • 资助金额:
    $ 34.32万
  • 项目类别:
Cellular Cofactors of Murine Leukemia Virus Integrase
鼠白血病病毒整合酶的细胞辅因子
  • 批准号:
    8709737
  • 财政年份:
    2014
  • 资助金额:
    $ 34.32万
  • 项目类别:
Cellular Cofactors of Murine Leukemia Virus Integrase
鼠白血病病毒整合酶的细胞辅因子
  • 批准号:
    8797297
  • 财政年份:
    2014
  • 资助金额:
    $ 34.32万
  • 项目类别:

相似海外基金

Determinants of Architecture on Retroviral Intasome Mechanics
逆转录病毒整合体力学结构的决定因素
  • 批准号:
    10651141
  • 财政年份:
    2023
  • 资助金额:
    $ 34.32万
  • 项目类别:
Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa
对移动医疗和传统依从性支持干预措施进行适应性评估,以优化南非耐药结核病和艾滋病毒新治疗方案的结果
  • 批准号:
    10589840
  • 财政年份:
    2022
  • 资助金额:
    $ 34.32万
  • 项目类别:
Sex differences in the role of multi-omicsin HIV-associated carotid artery atherosclerosis
多组学在 HIV 相关颈动脉粥样硬化中作用的性别差异
  • 批准号:
    10656874
  • 财政年份:
    2019
  • 资助金额:
    $ 34.32万
  • 项目类别:
Sex differences in the role of multi-omics in HIV-associated carotid artery atherosclerosis
多组学在 HIV 相关颈动脉粥样硬化中作用的性别差异
  • 批准号:
    10661140
  • 财政年份:
    2019
  • 资助金额:
    $ 34.32万
  • 项目类别:
Virologic and pharmacologic determinants of dolutegravir failure in East Africa
东非多替拉韦失败的病毒学和药理学决定因素
  • 批准号:
    10530639
  • 财政年份:
    2018
  • 资助金额:
    $ 34.32万
  • 项目类别:
Virologic and pharmacologic determinants of dolutegravir failure in East Africa
东非多替拉韦失败的病毒学和药理学决定因素
  • 批准号:
    10063968
  • 财政年份:
    2018
  • 资助金额:
    $ 34.32万
  • 项目类别:
Virologic and pharmacologic determinants of dolutegravir failure in East Africa
东非多替拉韦失败的病毒学和药理学决定因素
  • 批准号:
    10321907
  • 财政年份:
    2018
  • 资助金额:
    $ 34.32万
  • 项目类别:
Structural determinants for integrase pleiotropism in viral maturation
病毒成熟过程中整合酶多效性的结构决定因素
  • 批准号:
    10242905
  • 财政年份:
    2012
  • 资助金额:
    $ 34.32万
  • 项目类别:
Structural determinants for integrase pleiotropism in viral maturation
病毒成熟过程中整合酶多效性的结构决定因素
  • 批准号:
    9769789
  • 财政年份:
  • 资助金额:
    $ 34.32万
  • 项目类别:
Structural determinants for integrase pleiotropism in viral maturation
病毒成熟过程中整合酶多效性的结构决定因素
  • 批准号:
    9411652
  • 财政年份:
  • 资助金额:
    $ 34.32万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了